Haemonetics Corp. buy Needham & Company LLC
Start price
03.12.24
/
50%
€80.50
Target price
03.12.25
€106.36
Performance (%)
-14.29%
End price
04.12.25
€69.00
Summary
This prediction ended on 04.12.25 with a price of €69.00. The price of Haemonetics Corp. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -14.29%. Needham___Company_LL has a follow-up prediction for Haemonetics Corp. where he still thinks Haemonetics Corp. is a Buy. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Haemonetics Corp. | - | - | - |
| iShares Core DAX® | -1.104% | -6.084% | 0.866% |
| iShares Nasdaq 100 | 0.328% | 2.327% | 18.263% |
| iShares Nikkei 225® | -1.082% | -7.987% | 26.339% |
| iShares S&P 500 | -0.055% | 0.880% | 13.287% |
Comments by Needham___Company_LL for this prediction
In the thread Haemonetics Corp. diskutieren
Haemonetics Co. (NYSE: HAE) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $112.00 price target on the stock.
Ratings data for HAE provided by MarketBeat
In the thread Trading Haemonetics Corp.
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten
Current prediction by Needham___Company_LL for Haemonetics Corp.
Haemonetics Corp.
Start price
Target price
Perf. (%)
€58.50
18.03.25
18.03.25
€95.28
18.03.26
18.03.26
-11.97%
06.03.26
06.03.26
Stopped prediction by Needham___Company_LL for Haemonetics Corp.
Haemonetics Corp.
Start price
Target price
Perf. (%)
€60.00
08.05.25
08.05.25
€74.16
08.05.26
08.05.26
-14.17%
06.03.26
06.03.26
Haemonetics Corp.
Start price
Target price
Perf. (%)
€57.00
07.02.25
07.02.25
€104.18
07.02.26
07.02.26
-15.09%
08.02.26
08.02.26
Haemonetics Corp.
Start price
Target price
Perf. (%)
€84.00
15.11.24
15.11.24
€106.41
15.11.25
15.11.25
-25.60%
16.11.25
16.11.25
Haemonetics Corp.
Start price
Target price
Perf. (%)
€79.00
12.06.24
12.06.24
€103.42
12.06.25
12.06.25
-24.68%
13.06.25
13.06.25